Arovella Therapeutics Ltd. Health Care
Biotech Cancer Healthcare Pharmaceuticals

$0.050 (0%)

High $0.05	Low $0.05	Trades 132	Turnover $407,237	Volume 8,117,500
30 June 2023 at 3:59pm

Market Cap (6-Aug) $72,531,112 (0th)	Close (30-Jun) $0.050 0 (0%)	Volume (30-Jun) 8,117,500	Shortsold (16-Jun) 1,800 (0.00%) (662nd)
52w High $0.125	52w Low $0.058	P/E -	EPS -0.01

Short Interest

ASIC data, 16 Jun 2026

% Shorted

0.00%

vs 0.00% prior report

Most Shorted Rank

662nd

of 712 shorted ASX stocks

Peak Short

1.99%

Apr 2014

Days to Cover

0.0

at 50d avg vol

View full short position history →

	Subject
	ALA ALA Ann: Notification regarding unquoted securities - ALA
	1 (current) 2 3
	ALA ALA Ann: Proposed issue of securities - ALA
	ALA ALA Ann: ALA and IMU collaboration advances to next phase of testing
	ALA ALA Ann: Arovella to present at AACR conference
	ALA ALA Ann: Quarterly Appendix 4C and Activities Report
	ALA ALA Ann: Change in substantial holding
	ALA ALA Ann: Notice Under Section 708A
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Notice Under Section 708A
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Investor Presentation
	ALA ALA Ann: Proposed issue of securities - ALA
	ALA ALA Ann: AROVELLA COMPLETES $1.65M PLACEMENT
	ALA ALA Ann: Trading Halt
	ALA ALA Ann: Arovella Biotech Showcase Presentation
	ALA ALA Ann: Arovella appoints Chief Operating Officer
	ALA ALA Ann: Notification of cessation of securities - ALA
	ALA ALA Ann: ALA options cytokine technology to enhance iNKT platform
	ALA ALA Ann: Change of Director's Interest Notice x4
	ALA ALA Ann: Notification regarding unquoted securities - ALA
	ALA ALA Ann: Notice Under Section 708A
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Proposed issue of securities - ALA
	ALA ALA Ann: Change of Director's Interest Notice
	ALA ALA Ann: Notice Under Section 708A
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Proposed issue of securities - ALA
	ALA ALA Ann: Proposed issue of securities - ALA
	ALA ALA Ann: R&D Tax Incentive refund received
	ALA ALA Ann: Results of Annual General Meeting
	ALA ALA Ann: AGM FY22 Presentation
	ALA ALA Ann: Arovella to present at Biotech Showcase 2023
	ALA ALA Ann: Europe Patent to be granted for iNKT Cell Therapy Platform
	ALA ALA Ann: Quarterly Appendix 4C and Activities Report
	ALA ALA Ann: Arovella to close its Perth OroMist R&D Facility
	ALA ALA Ann: Notice of Annual General Meeting/Proxy Form
	ALA ALA Ann: Appendix 4G
	ALA ALA Ann: Corporate Governance Statement
	ALA ALA Ann: Annual Report to shareholders
	ALA ALA Ann: ALA iNKT therapy and IMU onCARlytics - correction
	ALA ALA Ann: Investor Presentation Imugene Arovella Therapies
	ALA ALA Ann: Preclinical trial of ALA iNKT therapy and IMU onCARlytics
	ALA ALA Ann: Notice Under Section 708A
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Proposed issue of securities - ALA
	ALA ALA Ann: Notification regarding unquoted securities - ALA
	ALA ALA Ann: Preliminary Final Report
	ALA ALA Ann: Application for quotation of securities - ALA
	ALA ALA Ann: Notification of cessation of securities - ALA

End of Day Prices

Date	Close	Volume	Change
06-Aug	$0.06	899,067	+0.00 (1.69%)
05-Aug	$0.06	96,083	0.00 (1.67%)
04-Aug	$0.06	88,591	0.00 (0.00%)
03-Aug	$0.06	167,200	0.00 (0.00%)
31-Jul	$0.06	616,426	0.00 (0.00%)
30-Jul	$0.06	1,224,504	0.00 (4.76%)
29-Jul	$0.06	1,437,635	0.00 (1.56%)
28-Jul	$0.06	265,398	0.00 (0.00%)
27-Jul	$0.06	855,690	0.00 (0.00%)
24-Jul	$0.06	208,094	0.00 (0.00%)
23-Jul	$0.06	297,092	0.00 (0.00%)
22-Jul	$0.06	74,699	0.00 (1.54%)
21-Jul	$0.07	0	0.00 (0.00%)
20-Jul	$0.07	257,069	0.00 (0.00%)
17-Jul	$0.07	329,893	-0.03 (31.58%)
1 up, 5 down, and 9 flat days

Arovella Therapeutics Ltd. Health Care
Biotech Cancer Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

End of Day Prices

ALA Arovella Therapeutics Ltd. Health Care Biotech Cancer Healthcare Pharmaceuticals

Short Interest

Followers

Prices

Announcements

End of Day Prices

Arovella Therapeutics Ltd. Health Care
Biotech Cancer Healthcare Pharmaceuticals